References
- Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The european organization for research and treatment of cancer qlq-c30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76. https://doi.org/10.1093/jnci/85.5.365
- Akin S, Can G, Durna Z, Aydiner A (2008). The quality of life and self-efficacy of turkish breast cancer patients undergoing chemotherapy. Eur J Oncol Nurs, 12, 449-56. https://doi.org/10.1016/j.ejon.2008.07.006
- Bourdeanu L, Frankel P, Yu W, et al (2012). Chemotherapyinduced nausea and vomiting in asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy. J Support Oncol, 10, 149-54. https://doi.org/10.1016/j.suponc.2011.10.007
- Cohen L, De Moor CA, Eisenberg P, et al (2007). Chemotherapyinduced nausea and vomiting-incidence and impact on patient quality of life at community oncology settings. Supp Care Cancer, 15, 497-503. https://doi.org/10.1007/s00520-006-0173-z
- Cohn SH, Vartsky D, Yasumura S, et al (1980). Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol, 239, 524-30.
- Dehkordi A, Heydarnejad MS, Fatehi D (2009). Quality of life in cancer patients undergoing chemotherapy. Oman Med J, 24, 204-7.
- Desalvo KB, Bloser N, Reynolds K, et al (2006). Mortality prediction with a single general self-rated health question: a meta-analysis. J Gen Intern Med, 21, 267-75. https://doi.org/10.1111/j.1525-1497.2005.00291.x
- Eisenbraun J, Scheer R, Kroz M, et al (2011). Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine, 18, 151-7. https://doi.org/10.1016/j.phymed.2010.06.013
- Fayers PM, Aaronson NK, Bjordal K, et al (2001). Eortc QLQ-C30 scoring manual, european organisation for research and treatment of cancer. Cancer Invest, 19, 573-80. https://doi.org/10.1081/CNV-100104284
- Gozzo T, Moyses A, Silva P, Almeida A (2013). Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy. Rev Gaucha Enferm, 34, 110-6. https://doi.org/10.1590/S1983-14472013000300014
- Helena M, Christina B, Bo N, Brandberg Y (2000). Healthrelated quality of life measured by the eortc qlq-c30: reference values from a large sample of the swedish population. Acta Oncologica, 39, 477-84. https://doi.org/10.1080/028418600750013384
- Holzner B, Kemmler G, Kopp M, et al (2001). Quality of life in breast cancer patients-not enough attention for long-term survivors?. Psychosomatics, 42, 117-23. https://doi.org/10.1176/appi.psy.42.2.117
- Kadowaki S,Yamaguchi K (2011). Chemotherapyinduced stomatitis and diarrhea. Gan to kagaku ryoho. Cancer Chemother Pharmacol, 38, 1761-6.
- Kallman D, Plato C, Tobin J (1990). The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. J Gerontol, 45, 82-8. https://doi.org/10.1093/geronj/45.3.M82
- Keefe D, Brealey J, Goland G, Cummins A ( 2000). Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut, 47, 632-7. https://doi.org/10.1136/gut.47.5.632
- Lua L, Zakaria NS, Mamat NM (2012). Health-related quality of life profile in relation to chemotherapy-induced nausea and vomiting among breast cancer patients. Asian J Psychiatr, 13.
- Magaji BA, Moy FM, Roslani AC, et al (2012). Health-related quality of life among colorectal cancer patients in malaysia: a study protocol. BMC Cancer, 12, 384. https://doi.org/10.1186/1471-2407-12-384
- MOH, Malaysia (2011). Chemotherapy protocols systemic therapy of cancer. Department of Radiotherapy and Oncology/ Hospital Kuala Lumpur, Ministry of Health Malaysia. .
- Melicher B & Zezulova M 2011. The significance of altered gastrointestinal permeability in cancer patients. Curr opin support palliat care, 5, 47-54. https://doi.org/10.1097/SPC.0b013e328343a043
- Mols F, Vingerhoets AJ, Coebergh JW, Van De Poll-Franse LV (2005). Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer, 41, 2613-9. https://doi.org/10.1016/j.ejca.2005.05.017
- Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer, 8, 330. https://doi.org/10.1186/1471-2407-8-330
- Ogce F, Ozkan S (2008). Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev, 9, 449-52.
- Pakhomov S, Jacobsen SJ, Chute CG, Roger VL (2008). Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care 14, 530-9.
- Palmer B, Walsh G, Mckinna J, Greening W (1980). Adjuvant chemotherapy for breast cancer: side effects and quality of life. BMJ, 281, 1594-7. https://doi.org/10.1136/bmj.281.6255.1594
- Royer HR, Phelan CH, Heidrich SM (2009). Older breast cancer survivors' symptom beliefs. Oncol nurs forum, 36, 463-70. https://doi.org/10.1188/09.ONF.463-470
- Russo F, Linsalata M, Clemente C, et al (2013). The effects of fluorouracil, epirubicin, and cyclophosphamide (fec60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer, 13, 56. https://doi.org/10.1186/1471-2407-13-56
- Rustoen T (1995). Hope and quality of life, two central issues for cancer patients: a theoretical analysis. Cancer Nurs, 18, 355-61.
- Scott N, Fayers P, Aaronson N, et al (2008). EORTC-QLQ-C30 reference values (2008). European organization for research and treatment of cancer, Brussels, Belgium.
- Sharma R, Tobin P, Clarke SJ (2005). Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol, 6, 93-102. https://doi.org/10.1016/S1470-2045(05)01735-3
- Singer P, Martin D, Kelner M (1999). Quality end-of-life care: patients' perspectives. JAMA, 281, 163-8. https://doi.org/10.1001/jama.281.2.163
- Valderas JM, Kotzeva A, Espallargues M, et al (2008). The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res, 17, 179-93. https://doi.org/10.1007/s11136-007-9295-0
- Watters JM, Yau JC, O'rourke K, et al (2003). Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol, 14, 1744-1750. https://doi.org/10.1093/annonc/mdg497
- Wolf I, Sadetzki S, Catane R, et al (2005). Diabetes mellitus and breast cancer. Lancet Oncol, 6, 103-11. https://doi.org/10.1016/S1470-2045(05)01736-5
- Yusoff N, Low W, Yip C (2010). The malay version of the european organization forresearch and treatment of cancer quality of life questionnaire (eortc-qlq c30): reliability and validity study. Med J Malaysia, 9, 45-50.
- Yusuf A, Abdul Hadi U, Mahamood Z, et al (2013). Quality of life in malay and chinese women newly diagnosed with breast cancer in kelantan, malaysia. Asian Pac J Cancer Prev, 14, 435-40. https://doi.org/10.7314/APJCP.2013.14.1.435
- Zainal AO, Nor Saleha IT (2011). The national cancer registry report. 2007. Ministry of health, Malaysia.